Searched for
EMCURE REVENUE GROWTH
Emcure Pharma shares jump 7% after Q2 profit rises 29% YoY to Rs 325 croreEmcure Pharmaceuticals shares rose up to 7.3% after the company reported a 29.3% year-on-year increase in Q2 FY27 profit to Rs 325.1 crore....- Stocks in news: ITC, Marico, SBI, Yatra Online, NSE, Container Corp and Sun PharmaIndian equity benchmarks experienced gains, with Nifty nearing the 23,500 resistance level and strong corporate earnings reported. ITC face...
- PE investor BC Investments sells Rs 612 crore stake in Emcure Pharma; Kotak MF picks up stakePrivate equity firm BC Investments IV sold a Rs 612 crore stake in Emcure Pharmaceuticals to Kotak Mahindra Mutual Fund at Rs 1,700 per sha...
- Emcure Pharma shares in focus after GST Department conducts search at Mumbai officesEmcure Pharmaceuticals' shares could see action following a Goods and Services Tax search at its Mumbai offices. The inspection concluded t...
- Emcure Pharma Q2 profit rises 25%, revenue up 13% on broad-based growthPune-based Emcure Pharmaceuticals reported a 13.4% year-on-year rise in consolidated revenue to ₹2,270 crore in the September quarter, supp...
- Emcure Pharmaceuticals reports 41% surge in Q1 net profit driven by strong domestic and international growthEmcure Pharmaceuticals reported a strong first quarter with a 41% increase in net profit, reaching Rs 215 crore, and a 16% rise in revenue ...
- Emcure Pharmaceuticals Q4 Results: Profit surges 63% YoY on strong domestic and international growthEmcure Pharmaceuticals reported a 63% YoY rise in Q4 net profit to Rs 197 crore, driven by strong domestic and international growth. EBITDA...
- Emcure Pharma Q3 net profit rises 30% YoY to Rs 156 croreEmcure Pharmaceuticals on Thursday reported a 30.3% year-on-year (YoY) increase in net profit to Rs.156 crore in Q3FY25 led by strong perfo...
- Emcure Pharma Q2 Results: Net profit rises 38% to Rs 202 crore, revenue jumps 20%Emcure Pharmaceuticals reported a 38.2% YoY rise in Q2FY25 net profit to Rs 202 crore, driven by strong domestic and international sales. R...
- Hot stocks: Brokerage view on Bajaj Auto, Emcure Pharma, LTIMindtree and Bajaj FinanceCLSA maintains an underperform rating on Bajaj Auto with a target price of Rs 7,000. The recent launch of entry-level motorcycles by Bajaj ...
- Emcure Q1 Results: Net profit rises 8.2% to Rs 153 crore, revenue up 16%Emcure Pharmaceuticals saw an 8.2% rise in net profit for Q1FY25, reaching Rs 153 crore due to strong sales in India and abroad. Revenue fr...
- Emcure Pharma shares debut with 31% premium over issue priceBefore listing, the company's shares traded at a Rs 360 premium in the grey market. It raised Rs 582 crore from anchor investors, including...
- Emcure Pharmaceuticals IPO share allotment likely on Monday. Here's how you can check the status.
- Emcure Pharmaceuticals IPO booked nearly 68 times so far on Day 3. Check GMP and other detailsEmcure Pharmaceuticals IPO sees strong demand with oversubscription. Anchor investors include top names. Company engaged in global pharmace...
- Emcure Pharmaceuticals IPO fully subscribed on Day 1. Check GMP and other detailsEmcure Pharmaceuticals' IPO attracts high demand from investors, with a price range of Rs 960-1008 per share. Analysts foresee business imp...
- Emcure Pharmaceuticals IPO booked nearly 5x so far on Day 2. Check GMP and other detailsEmcure Pharmaceuticals' IPO has been oversubscribed nearly three times as of Thursday, the second day of bidding. The bidding concludes on ...
- IPO Analysis: Emcure has better-listed pharma alternativesEmcure Pharma, with its strong presence in gynaecology and HIV therapeutic areas, secured significant investments from anchor investors lik...
- Emcure Pharmaceuticals IPO: 10 things to know before subscribing to the issueEmcure Pharmaceuticals IPO is scheduled to open for subscription on July 3 and will close on July 5. The company aims to raise approximatel...
- Blackstone to sell its stake in Emcure Pharma to Bain CapitalPrivate equity major Blackstone is selling its stake in Pune-based Emcure Pharmaceuticals to Bain Capital.
- Apax, KKR in talks to acquire Blackstone stake in EmcureHealthcare is 1 of the 5 sectors in which Apax Partners invests globally, besides technology & telecom, retail & consumer, media, financial...
Load More- Emcure Pharma shares in focus after GST Department conducts search at Mumbai offices
